Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole ER in Fibromyalgia
NCT00689052Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2008
- Primary completion
- Nov 2008
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing Pramipexole ER with Placebo (2 arms). Primary endpoint: Weekly Mean of the 24-hour Average Pain Score at 29 weeks. Started Jul 2008; status: terminated.
02
Drugs
pramipexole
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00689052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00689052.